Evidence & regulatory context
- Mechanism
- Not recorded
- Target
- Not recorded
- Injury models
- Fracture
- Reported indication
- Not recorded
- First approval
- Not recorded
- Development stage
- Not recorded
- ChEMBL record
- Not recorded
- ChEMBL max phase
- Not recorded
- Synonyms
- Not recorded
- Note
- Not recorded
Clinical trials 0
0 linked trials carry an injury-indication flag. These flags support record-level exploration and sit alongside the stringent aggregate counts described in Methods.
No linked human trial in this dataset.
Preclinical evidence 1
1 studies reported at therapy level; 1 evidence entries itemised.
MixedFractureUnspecifiedSprague-Dawley rats; rabbitsMalesystemic (rats); local (rabbits)after fracture/defect
Model: long bone fracture (rat) and critical-size ulna defect (rabbit)
Recombinant BMP1-3 enhanced bone healing while its neutralisation delayed union, indicating a role in bone repair.
Extraction: extract · Supplied extraction confidence: 0.75. Machine-extracted fields require source verification.
